trending Market Intelligence /marketintelligence/en/news-insights/trending/VZeamjBU1diY9981SH0krg2 content esgSubNav
In This List

Rosetta Genomics receives extension to regain compliance with Nasdaq

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Rosetta Genomics receives extension to regain compliance with Nasdaq

Nasdaq granted Rosetta Genomics Ltd. an extension to regain compliance with the exchange's listing requirement.

Under the extension, Rosetta Genomics must close its previously announced acquisition by Genoptix Inc. by April 23, 2018.

In case the deal does not go through, the company must raise equity to comply with the exchange's requirement.